These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 15577680
1. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Tsuzuki T, Magi-Galluzzi C, Epstein JI. Am J Surg Pathol; 2004 Dec; 28(12):1609-14. PubMed ID: 15577680 [Abstract] [Full Text] [Related]
2. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP. Mod Pathol; 2007 May; 20(5):592-603. PubMed ID: 17396140 [Abstract] [Full Text] [Related]
3. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI. Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [Abstract] [Full Text] [Related]
4. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA. Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478 [Abstract] [Full Text] [Related]
5. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder. Bertz S, Stöhr R, Gaisa NT, Wullich B, Hartmann A, Agaimy A. Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760 [Abstract] [Full Text] [Related]
6. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Coffin CM, Hornick JL, Fletcher CD. Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097 [Abstract] [Full Text] [Related]
7. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall. Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, Hirota S, Haga H, Katsuyama E. World J Surg Oncol; 2014 Jun 18; 12():186. PubMed ID: 24938355 [Abstract] [Full Text] [Related]
8. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations. Choi E, Williamson SR, Montironi R, Zhang S, Wang M, Eble JN, Grignon DJ, Lopez-Beltran A, Idrees MT, Baldridge LA, Scarpelli M, Jones CL, Wang L, MacLennan GT, Osunkoya AO, Cheng L. Histopathology; 2015 Jul 18; 67(1):20-38. PubMed ID: 25406945 [Abstract] [Full Text] [Related]
9. Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining. Rao RN, Ranjan P, Singla N, Pandey R. Urol Ann; 2012 May 18; 4(2):115-8. PubMed ID: 22629012 [Abstract] [Full Text] [Related]
10. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, Daines C, Coffin CM. Mod Pathol; 2002 Sep 18; 15(9):931-8. PubMed ID: 12218210 [Abstract] [Full Text] [Related]
11. Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review. Teoh JY, Chan NH, Cheung HY, Hou SS, Ng CF. Urology; 2014 Sep 18; 84(3):503-8. PubMed ID: 25168523 [Abstract] [Full Text] [Related]
12. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract. Hirsch MS, Dal Cin P, Fletcher CD. Histopathology; 2006 Apr 18; 48(5):569-78. PubMed ID: 16623783 [Abstract] [Full Text] [Related]
13. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Westfall DE, Folpe AL, Paner GP, Oliva E, Goldstein L, Alsabeh R, Gown AM, Amin MB. Am J Surg Pathol; 2009 Jan 18; 33(1):99-105. PubMed ID: 18941404 [Abstract] [Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL. Am J Surg Pathol; 2011 Jan 18; 35(1):135-44. PubMed ID: 21164297 [Abstract] [Full Text] [Related]
15. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X, Montgomery E, Sun B. Hum Pathol; 2008 Jun 18; 39(6):846-56. PubMed ID: 18400254 [Abstract] [Full Text] [Related]
17. [Inflammatory myofibroblastic tumors of the urinary bladder: a clinicopathological study of ten cases]. Zhang HZ, Wang SY, Dong L, Yang XQ, Wang CF. Zhonghua Bing Li Xue Za Zhi; 2021 Sep 08; 50(9):1024-1028. PubMed ID: 34496493 [Abstract] [Full Text] [Related]
18. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Freeman A, Geddes N, Munson P, Joseph J, Ramani P, Sandison A, Fisher C, Parkinson MC. Mod Pathol; 2004 Jul 08; 17(7):765-71. PubMed ID: 15105807 [Abstract] [Full Text] [Related]